Back to search

Article

Low dose naltrexone for the treatment of fibromyalgia: Protocol for a double-blind, randomized, placebo-controlled trial

2021-04-08

Abstract excerpt

<title>Abstract</title> <p><bold>Background </bold>Low dose naltrexone (LDN) is used widely as off-label treatment for pain despite limited evidence for its effectiveness. A few small trials with high risk of bias have investigated the effect of LDN on pain associated with fibromyalgia in women, but larger and more methodologically robust studies are needed. The primary aim of this randomized controlled trial is...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
eda262ce-581e-5e6f-859e-43447b6fefd7
DOI
10.21203/rs.3.rs-401663/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Low dose naltrexone for the treatment of fibromyalgia: Protocol for a double-blind, randomized, placebo-controlled trialDOI 10.21203/rs.3.rs-401663/v1
Select a neighboring publication to make it the new centre.